UBE2Q2P11: A Drug Target / Disease Biomarker (G100421767)

Target Name: UBE2Q2P11

NCBI ID: G100421767

UBE2Q2P11

Other Name(s): UBE2Q2 pseudogene 11

UBE2Q2P11: A Drug Target / Disease Biomarker

UBE2Q2P11 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the UBE2Q2 family of proteins, which are known for their role in the regulation of mitochondrial function and energy metabolism. UBE2Q2P11 has been shown to play a key role in the regulation of mitochondrial dynamics and has been identified as a potential drug target.

The UBE2Q2P11 protein is composed of 21 amino acid residues and has a calculated molecular weight of 33 kDa. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and has been shown to localize to the mitochondria of these tissues. UBE2Q2P11 is a protein that is primarily composed of alpha-helices, which are long, linear regions of amino acids that are characterized by their ability to fold into specific shapes.

The UBE2Q2P11 protein is involved in a number of cellular processes that are important for maintaining cellular homeostasis. For example, it is involved in the regulation of mitochondrial fusion, which is the process by which mitochondria fuse with one another to form a single mitochondium. UBE2Q2P11 is also involved in the regulation of mitochondrial dynamics, which is the movement of mitochondria into and out of the mitochondrial membrane.

In addition to its role in regulating mitochondrial function, UBE2Q2P11 has also been shown to play a key role in the regulation of cellular signaling pathways. For example, it has been shown to be involved in the regulation of the production of reactive oxygen species (ROS), which are toxic to cellular components and can contribute to a variety of cellular stressors, including oxidative stress and DNA damage.

The identification of UBE2Q2P11 as a potential drug target is based on its ability to interact with a variety of drug molecules, including small molecules, peptides, and proteins. For example, studies have shown that UBE2Q2P11 can interact with drugs that are used to treat a variety of cellular stressors, including oxidative stress, inflammation, and neurodegenerative diseases.

In addition to its potential as a drug target, UBE2Q2P11 also has potential as a biomarker. Studies have shown that UBE2Q2P11 is expressed in a variety of tissues and that its levels can be affected by a variety of cellular stressors, including oxidative stress and inflammation. This suggests that UBE2Q2P11 may be a useful biomarker for the diagnosis and treatment of a variety of cellular stressors.

Overall, UBE2Q2P11 is a protein that is involved in a variety of cellular processes that are important for maintaining cellular homeostasis. Its potential as a drug target and biomarker makes it an attractive target for further research and development.

Protein Name: UBE2Q2 Pseudogene 11

The "UBE2Q2P11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about UBE2Q2P11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets